SEPOY.net
No Result
View All Result
Tuesday, June 17, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

Combining surrogate markers of kidney disease progression improves predictions of treatment effects on clinical endpoints

Nicholas by Nicholas
November 6, 2022
in Health
0
Combining surrogate markers of kidney disease progression improves predictions of treatment effects on clinical endpoints

Change in urinary albumin:creatinine ratio (UACR) and glomerular filtration rate (GFR) slope are markers that are individually used as surrogates of chronic kidney disease progression in clinical trials. Investigators recently developed a strategy that combines information from the treatment effects on the two to improve the prediction of treatments’ effects on patient outcomes. Their research will be presented at ASN Kidney Week 2022 November 3–November 6.

READ ALSO

Aging family physician workforce challenges primary care in Ontario

Supermarket ads push junk food for toddlers and infants

The scientists used data from 41 randomized controlled trials of chronic kidney disease progression to develop their strategy and then applied the results to the design of a phase 2 trial to assess design implications (such as sample size and follow-up time) for using UACR change and GFR slope individually or in combination.

The analysis revealed that in phase 2 clinical trials with sample sizes of 100–200 patients per arm or follow-up times ranging between 1 and 2 years, combining UACR change and GFR slope improves predictions of treatments’ effects on clinical endpoints.

“Currently, UACR change and GFR slope are often evaluated as separate endpoints in phase 2 trials; however, it is not clear how to integrate the information provided by these two endpoints,” said corresponding author Tom Greene, PhD, of the University of Utah. “This work presents a 2-step methodology for addressing this problem. In the first step, a Bayesian model is used to characterize the relationships among the treatment effects on UACR, GFR slope, and the clinical endpoint across previous randomized trials. In the second step, this model is used to provide a unified estimate of the probability of clinical benefit based on the estimated effects of the treatment on UACR change and GFR slope in a new phase 2 trial.”

Source:

American Society of Nephrology

Source

Tags: AlbuminChronicChronic Kidney DiseaseCreatinineKidneyKidney DiseaseNephrologyResearch

Related Posts

Aging family physician workforce challenges primary care in Ontario
Health

Aging family physician workforce challenges primary care in Ontario

June 17, 2025
Supermarket ads push junk food for toddlers and infants
Health

Supermarket ads push junk food for toddlers and infants

June 17, 2025
Estrogen-responsive cells found to heighten gut pain in females
Health

Estrogen-responsive cells found to heighten gut pain in females

June 17, 2025
First patient treated in international clinical trial for rare muscle-weakness disease
Health

First patient treated in international clinical trial for rare muscle-weakness disease

June 16, 2025
Paternal mental health found to impact child development
Health

Paternal mental health found to impact child development

June 16, 2025
Two existing medications work effectively together in treating alcohol use disorder
Health

Two existing medications work effectively together in treating alcohol use disorder

June 16, 2025
Next Post
Research reveals direct and indirect impacts of COVID-19 pandemic on the mortality of hemodialysis patients

Research reveals direct and indirect impacts of COVID-19 pandemic on the mortality of hemodialysis patients

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Gamble Dual Spin Free Zero Download free Demo Position
  • 100 percent free Ports Having Bonus from the slot turning totems Gambino Public Local casino
  • All-american Poker by the Habanero Demonstration Play Totally free Gambling establishment 1 deposit casinos Game

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net